Gene Profiling of Human Induced Pluripotent Stem Cell-Derived Astrocyte Progenitors Following Spinal Cord Engraftment

Stem Cells Translational Medicine

Volumn 3, Issue 5, 2014, Pages 575-585

  Haidet Phillips, Amanda M ^a   Roybon, Laurent ^b,c   Gross, Sarah K ^a   Tuteja, Alisha ^a   Donnelly, Christopher J ^a   Richard, Jean Philippe ^a   Ko, Myungsung ^a   Sherman, Alex ^a   Eggan, Kevin ^d   Henderson, Christopher E ^b   Maragakis, Nicholas J ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Medicine   (United States)

^c LUND UNIVERSITY   (Sweden)

^d Harvard University   (United States)

Author keywords

Astrocytes; Gene profiling; Human induced pluripotent stem cells; Stem cell transplantation

Indexed keywords

TRANSCRIPTOME;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL LINEAGE; CELL MATURATION; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL DIFFERENTIATION; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; RAT; RNA ISOLATION; SPINAL CORD TRANSPLANTATION; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ASTROCYTES; GENE PROFILING; HUMAN INDUCED PLURIPOTENT STEM CELLS; STEM CELL TRANSPLANTATION;

ANIMALS; ASTROCYTES; CELL DIFFERENTIATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HETEROGRAFTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MICE; NEURAL STEM CELLS; RATS; RATS, SPRAGUE-DAWLEY; SPINAL CORD;

EID: 84899704182     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2013-0153     Document Type: Article

References (40)

1. Lukovic D, Moreno Manzano V, Stojkovic M et al. Concise review: Human pluripotent stem cells in the treatment of spinal cord injury. STEM CELLS 2012;30:1787-1792.
2. Papadeas ST, Maragakis NJ. Advances in stem cell research for amyotrophic lateral sclerosis. Curr Opin Biotechnol 2009;20:545-551.
3. Uccelli A, Laroni A, Freedman MS. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol 2011;10:649-656.
4. De Feo D, Merlini A, Laterza C et al. Neural stem cell transplantation in central nervous system disorders: From cell replacement to neuroprotection. Curr Opin Neurol 2012;25:322-333.
5. Takahashi K, Tanabe K, OhnukiMet al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872.
6. Goldman SA, Nedergaard M, Windrem MS. Glial progenitor cell-based treatment and modeling of neurological disease. Science 2012; 338:491-495.
7. Wang S, Bates J, Li X et al. Human iPSCderived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell 2013; 12:252-264.
8. Schwartz SD, Hubschman JP, Heilwell G et al. Embryonic stem cell trials for macular degeneration: A preliminary report. Lancet 2012; 379:713-720.
9. Bellin M, Marchetto MC, Gage FH et al. Induced pluripotent stem cells: The new patient? Nat Rev Mol Cell Biol 2012;13:713-726.
10. Ito D, Okano H, Suzuki N. Accelerating progress in induced pluripotent stem cell research for neurological diseases. Ann Neurol 2012;72:167-174.
11. Ilieva H, Polymenidou M, Cleveland DW. Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J Cell Biol 2009;187:761-772.
12. Molofsky AV, Krencik R, Ullian EM et al. Astrocytes and disease: A neurodevelopmental perspective. Genes Dev 2012;26:891-907.
13. Fujimoto Y, Abematsu M, Falk A et al. Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term selfrenewing neuroepithelial-like stem cells. STEM CELLS 2012;30:1163-1173.
14. Major T, MenonJ, AuyeungGet al. Transgene excision has no impact on in vivo integration of human iPS derived neural precursors. PLoS One 2011;6:e24687.
15. Nori S, Okada Y, Yasuda A et al. Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proc Natl Acad Sci USA 2011;108:16825-16830.
16. Boulting GL, Kiskinis E, Croft GF et al. A functionally characterized test set of human induced pluripotent stem cells. Nat Biotechnol 2011;29:279-286.
17. Lepore AC, Rauck B, Dejea C et al. Focal transplantation-based astrocyte replacement is neuroprotective in a model of motor neuron disease. Nat Neurosci 2008;11:1294-1301.
18. Cowan CA, Klimanskaya I, McMahon J et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004; 350:1353-1356.
19. Roybon L, Lamas NJ, Garcia-Diaz A et al. Human stem cell-derived spinal cord astrocytes with defined mature or reactive phenotypes. Cell Rep 2013;4:1035-1048.
20. Liu Y, Han SS, WuY et al. CD44 expression identifies astrocyte-restricted precursor cells. Dev Biol 2004;276:31-46.
21. Yuan SH, Martin J, Elia J et al. Cell-surface marker signatures for the isolation of neural stem cells, gliaandneuronsderivedfromhumanpluripotent stem cells. PLoS One 2011;6:e17540.
22. Zamanian JL, Xu L, Foo LC et al. Genomic analysis of reactive astrogliosis. J Neurosci 2012;32:6391-6410.
23. Lee S, Park JY, LeeWHet al. Lipocalin-2 is an autocrine mediator of reactive astrocytosis. J Neurosci 2009;29:234-249.
24. Bi F, Huang C, Tong J et al. Reactive astrocytes secrete lcn2 to promote neuron death. Proc Natl Acad Sci USA 2013;110:4069-4074.
25. Geiss GK, Bumgarner RE, Birditt B et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol 2008;26:317-325.
26. Cahoy JD, EmeryB, KaushalAet al. Atranscriptome database for astrocytes, neurons, and oligodendrocytes: A new resource for understanding brain development and function. J Neurosci 2008;28:264-278.
27. JeonI, LeeN, Li JYetal. Neuronal properties, in vivoeffects, andpathologyofaHuntington'sdisease patient-derived induced pluripotent stem cells. STEM CELLS 2012;30:2054-2062.
28. Lepore AC, O'Donnell J, Kim AS et al. Human glial-restricted progenitor transplantation into cervical spinal cord of the SOD1 mouse model of ALS. PLoS One 2011;6:e25968.
29. Han X, Chen M, Wang F et al. Forebrain engraftment by human glial progenitor cells enhances synaptic plasticity and learning in adult mice. Cell Stem Cell 2013;12:342-353.
30. Krencik R, Weick JP, Liu Y et al. Specification of transplantable astroglial subtypes from human pluripotent stem cells. Nat Biotechnol 2011;29:528-534.
31. Rothstein JD, Van Kammen M, Levey AI et al. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84.
32. Bristol LA, Rothstein JD. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex. Ann Neurol 1996;39: 676-679.
33. Bendotti C, Tortarolo M, Suchak SK et al. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels. J Neurochem 2001;79:737-746.
34. Doi A, Park IH, Wen B et al. Differential methylation of tissue-and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
35. Ohi Y, Qin H, Hong C et al. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol 2011;13:541-549.
36. Zhao T, Zhang ZN, Rong Z et al. Immunogenicity of induced pluripotent stem cells. Nature 2011;474:212-215.
37. Chin MH, Pellegrini M, Plath K et al. Molecular analyses of human induced pluripotent stem cells and embryonic stem cells. Cell Stem Cell 2010;7:263-269.
38. Bock C, Kiskinis E, VerstappenGet al. Reference maps of human ES and iPS cell variation enable high-throughput characterization of pluripotent cell lines. Cell 2011;144:439-452.
39. Osafune K, Caron L, Borowiak M et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 2008;26:313-315.
40. Hu BY, Weick JP, Yu J et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency. Proc Natl Acad Sci USA 2010; 107:4335-4340.